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  A B S T R A C T  
  I n t r o d u c t i o n       Observational studies report inverse 
associations between the use of feather upper bedding 
(pillow and/or quilt) and asthma symptoms but there is 
no randomised controlled trial (RCT) evidence   assessing 
the role of feather upper bedding as a secondary 
 prevention  measure.  
  O b j e c t i v e       To determine whether, among children not 
using feather upper bedding, a new feather pillow and 
feather quilt reduces asthma severity among house 
dust mite (HDM) sensitised children with asthma over 
a 1-year period compared with standard dust mite 
  avoidance advice, and giving children a new mite-
  occlusive mattress cover.   
  D e s i g n     R C T.   
  S e t t i n g       The Calvary Hospital in the Australian Capital 
Territory and the Children’s Hospital at Westmead, 
Sydney, New South Wales.   
  P a t i e n t s       197 children with HDM sensitisation and 
  moderate to severe asthma.   
  I n t e r v e n t i o n       New upper bedding duck feather pillow 
and quilt and a mite-occlusive mattress cover (feather) 
versus standard care and a mite-occlusive mattress 
cover (standard).   
  Main  outcome  measures      The proportion of children 
reporting four or more episodes of wheeze in the past 
year; an episode of speech-limiting wheeze; or one or 
more episodes of sleep disturbance caused by wheezing; 
and spirometry with challenge testing. Statistical analysis 
included multiple logistic and linear regression.   
  R e s u l t s       No differences between groups were found for 
primary end points – frequent wheeze (OR 1.51, 95% CI 
0.83 to 2.76, p=0.17), speech-limiting wheeze (OR 0.70, 
95% CI 0.32 to 1.48, p=0.35), sleep disturbed because 
of wheezing (OR 1.17, 95% CI 0.64 to 2.13, p=0.61) 
or for any secondary end points. Secondary analyses 
indicated the intervention reduced the risk of sleep being 
disturbed because of wheezing and severe wheeze to a 
greater extent for children who slept supine.   
  C o n c l u s i o n       No differences in respiratory symptoms 
or lung function were observed 1 year after children 
with moderate–severe asthma and HDM sensitisation 
were given a mite-occlusive mattress cover and then 
received either feather upper bedding (pillow and quilt) 
or   standard  bedding  care.      
  I N T R O D U C T I O N   
  Over the past two decades, studies have reported an 
inverse association between feather upper bedding 
and asthma symptoms.    1     –      4    In Australia, we found 
that this inverse association is stronger in house 
dust mite (HDM) sensitised children.    5    In a North 
European birth cohort, children using feather bed-
ding by age 4 were less likely to develop wheeze.    6    
  Synthetic bedding may be more adverse than 
feather bedding because synthetic bedding may 
have higher levels of HDM allergens,    7        8    pro-
inﬂ   ammatory fungal cell wall β-(1,3)-glucans,    9    
volatile organic compounds,    1    and lower levels of 
bacterial endotoxins.    10    Alternatively, the asso-
ciation between synthetic bedding and wheeze 
in one study was partly accounted for by changes 
in bedding which occurred after the development 
of wheeze.    11    A 2007 Cochrane review could not 
identify any randomised controlled trial (RCT) 
evidence assessing the role of feather upper bed-
ding as a secondary prevention intervention in 
asthma.    12    Previously, randomised trials have 
shown that HDM reduction strategies have not 
b e e n  e ff e cti v e ,  e v e n  am o ng  th e  s u b s e t  o f  trials  
that have documented HDM reduction on mat-
tresses.    13    This may indicate that other aspects of 
a child’s environment such as upper bedding may 
be important. The conﬂ  icting ﬁ  ndings about bed-
ding interventions and asthma may also reﬂ  ect 
that there are modiﬁ  ers of the association between 
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What is already known on this topic
       O b s e r v a t i o n a l   e p i d e m i o l o g i c a l   s t u d i e s   h a v e     ▶
reported that children who sleep with feather 
pillows and quilts have lower rates of wheeze.        
    Feather bedding has been reported to have    ▶
lower Der p 1 dust mite levels than synthetic 
b e d d i n g .       
    Child sleep position has been shown to alter    ▶
the association between upper bedding type 
and  wheeze.   
What this study adds
       New  feather  bedding  was  not  associated    ▶
with an altered risk of wheeze symptoms lung 
  function or quality of life after 12 months.        
    This trial does not support recommendations    ▶
that feather bedding should be avoided for 
 children  with  asthma.      
    Child sleep position should be taken into    ▶
account for trials examining the bedding 
 environment  and  asthma.   
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bedding and wheeze. For example, we have previously shown 
that the adverse effect of synthetic quilt use on child wheeze 
or lung function is substantially more evident for children who 
sleep supine compared with those who do not.    14    
  Here, we report on an RCT to determine whether, among 
children not using feather upper bedding, a new feather pil-
low and quilt (feather) reduces asthma severity among HDM 
sensitised children with asthma over a 1-year period compared 
with dust mite avoidance advice    15    (standard) when all children 
are also given a new mite-occlusive mattress cover.   
  M E T H O D S  
  Study  design 
  A RCT was conducted at two sites (Calvary Hospital in the 
Australian Capital Territory (ACT) and the Children’s Hospital 
at Westmead, Sydney, New South Wales (NSW)).   
  Methods  of  recruitment 
  Recruitment occurred from January 2002 to December 2004 
through advertising in schools, emergency departments, 
general practices and paediatric respiratory clinics. Written 
informed consent was obtained from parents or carers.   
  Trial  eligibility 
  E l i g i b i l i t y  c r i t e r i a  w e r e :  a g e d  7 – 1 4  y e a r s ;  d i a g n o s e d  w i t h  
asthma; asthma symptoms including wheeze; four or more 
episodes of wheeze per year or an episode of speech-limiting 
wheeze in the past 12 months; HDM sensitised    16    (skin prick 
te s t  w e al  s iz e  ≥3    mm  t o    Dermatophagoides pteronyssinus   and/
or   Dermatophagoides farina  ); not sensitised to feather (weal size 
<3   mm to feather extract); not sensitised to cat pelt (weal size 
<3 mm to cat pelt extract) if there was a cat at home; not having 
a feather pillow or quilt on their bed at study entry; single bed 
use; and plan to remain in the study region for the next 2 years.   
    Trial interview schedule and study sample 
  A total of 759 children were assessed for eligibility (ﬁ  gure 1  ). 
One hundred and ninety-seven children were randomised, had 
baseline interviews, spirometric assessments completed and 
a home visit to apply the bedding changes. Phone interviews 
were conducted every 3 months with follow-up home visits 
and clinic assessments at 12 months postintervention. The 
interviews collected data on respiratory symptoms, quality of 
life and other factors such as usual sleep position by asking: 
‘What position does your child usually sleep in?’ and providing 
options including ‘on the back’ (supine).    14      
  Randomisation  and  blinding 
  Block randomisation with age blocks by year of birth was 
used. The ‘biased coin’ method was used to minimise the 
likelihood that group allocation differed by season.    17    Patient 
blinding was achieved by providing interventions to both the 
feather and standard groups. Each participant, regardless of 
group allocation, was informed that they had been allocated 
to a bedding group with some evidence to support its use 
in asthma. Research nurses conducting clinical assessments 
were blind to group assignment. An independent statistician, 
also blind to group assignment, undertook the ﬁ  rst analyses.   
  Feather  group 
  Parents and children were supplied with and instructed to 
use only the feather upper bedding (pillow and quilt), with 
no other forms of upper bedding apart from sheets. On hot 
nights, the replacement use of thin cotton covers was permit-
ted. Standard commercial practice meant the duck feather and 
down bedding had been prewashed in hot water, chemically 
treated and hot air dried by the manufacturer before use, with 
documentation of the procedures used (Myer House Brand, 
Hangzhou, China). 
  Feather pillows were used all year. A mite-occlusive cover 
(Auspharm, Surrey Hills, NSW , Australia   ) was ﬁ  tted to the 
mattress.   
  Standard  group 
  This group received verbal and written advice from the 
research nurse at baseline explaining the bedding advice 
from the National Asthma Campaign (applicable at the 
time).    15    This included the use of pillow, quilt and mattress 
mite-proof covers, weekly washing of bedclothes in hot (over 
55°C) water and weekly dusting of bedrooms using damp 
cloths. A mite-occlusive cover (Auspharm) was also ﬁ  tted to 
the mattress.   
  Trial  outcome  measures 
  Based on previous Australian reports,    5        14    primary end points 
were measured at baseline and at 12 months postintervention. 
They were: the proportion of children reporting four or more 
episodes of wheeze; an episode of speech-limiting wheeze; or 
reporting one or more episodes of sleep disturbed because of 
wheezing in a week. Each child was assessed using previously 
validated questions from the International Study of Asthma 
and Allergy in Childhood.    18    Secondary end points included 
spirometry with challenge testing, quality of life assessments 
using the Juniper Paediatric Quality of Life Questionnaire    19    and 
medication use. Spirometry at baseline and end point included 
forced expiratory volume in 1 s (FEV   1  ), forced vital capacity 
(FVC), the FEV  1  /FVC ratio and the relative and absolute change 
in FEV  1   after challenge.    19    For ACT children, the challenge was 
by cold air for 4 min at −10 to −15°C (Jaeger cold air system; 
Wuerzburg, Germany  ) but for NSW children the challenge was 
by methacholine.    20       
    Environmental outcomes: HDM allergen levels 
  In past studies, HDM allergen exposures have often been 
assessed as the concentration of allergen in dust from bed-
room ﬂ  oors and the child’s bedding. More recently, airborne 
or inhaled allergen levels have been used to more accurately 
measure exposure. Here, inhaled HDM (Der p 1) aeroaller-
gen exposure was sampled using model 2 nasal air samplers 
(NAS),    21    worn by children for 10 min after getting into bed 
each night, for four nights. A sampling protocol, played on a 
CD player, describing bed entry and gentle movements, was 
used to emulate natural sleep disturbance and standardise 
disturbance. NAS were previously coated internally with 
an adhesive which collected impacted particles, which were 
extracted with 0.7 ml of 1% bovine serum albumin, 0.05% 
Tween, phosphate buffered saline buffer and analysed for Der 
p 1. Additionally, ambient nocturnal aeroallergen exposure was 
sampled using 25 mm GF/A glass ﬁ  bre air ﬁ  lters (Whatman 
International, Maidstone, UK) as described,    22    held in an 
Institute of Occupational Medicine Inhalable Sampling Head 
(SKC, Dorset, UK), located within 1 metre of the pillow and 
connected to a diaphragm pump with airﬂ  ow of 2.0 litre/min. 
Samples were managed by an electronic timer and collected 
for 6 h after going to bed each night for 4 nights (providing a 
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cumulative 24 h sample in total). Filters were extracted in 1.0 
ml of the same buffer as the NAS. 
  Der p 1 allergen was measured by a conventional 
ELISA assay (10B9/5H8) (EL-DP1; Indoor Biotechnologies, 
Cardiff, UK) modiﬁ  ed by the authors to use Poly-HRP80-
Streptavidin conjugate (RDI, Flanders, New Jersey, USA) 
and SureBlueTMB Microwell Peroxidase (KPL, Gaithersburg, 
Maryland, USA  ) to increase the sensitivity to 9.8 pg/ml. 
Samples below this were assigned an arbitrary value of 1 
pg/ml for calculations. 
  The study was approved by the Human Research Ethics 
Committee of the Australian Capital Territory Department 
of Health, the Research Ethics Committee of the Sydney 
South West Area Health Service, and the Sydney and Human 
R e s e a r c h  E t h i c s  C o m m i t t e e  a t  t h e  C h i l d r e n ’ s  H o s p i t a l  a t  
Westmead, Sydney.      
  Statistical  analyses 
  The study aimed to recruit 200 children because this sample 
would allow the detection of an RR of 0.78 or less associated 
with feather bedding (an effect size of at least a 22% reduc-
ti on)  if  90 %  o f  controls  repo rted  symptoms  o f  frequent  o r  
severe or nocturnal wheeze.    5        14        24     Also, 178 children would be 
required to detect a difference in FEV  I  /FVC ratio of 2.1% with 
p<0.05 at 90% power.    25     In a previous cross-sectional study, 
the authors reported that children with HDM sensitisation 
who slept without a feather quilt had a lower FEV  I  /FVC ratio 
than non-HDM sensitised children who slept under a feather 
quilt (adjusted difference −0.68%, 95% CI −1.24% to −0.13%) 
but children with HDM sensitisation who slept with a feather 
quilt did not have a lower FEV  I  /FVC ratio (adjusted difference 
−0.31%, 95% CI −1.33% to 0.71%).    5    
  The main form of analysis was on an intention-to-treat 
basis. A secondary analysis by compliance was also conducted. 
Baseline refers to the randomisation visit and end point refers 
to the ﬁ  nal visit at 12 months. The treatment effects for the 
dichotomous outcomes were assessed using OR estimates from 
a multiple logistic regression model with adjustment for factors 
as listed in the table footnotes or additional medication or cover 
use. The treatment effects for the change in quality of life or 
lung function tests were assessed using multiple linear regres-
sion models. 
  The assessment of treatment effects by challenge were 
analysed separately for each site because of the different chal-
lenges employed. For the cold air challenge the model used is 
similar to the one used for change in FEV  1   from baseline to end 
point, except the outcome is the relative/absolute difference in 
FEV  1   because of the challenge. 
  For the methacholine challenge the outcome of interest is 
the dose at which the target FEV  1   is reached. To evaluate the 
treatment effect a multiple linear regression model of square 
root of dose adjusted for baseline value, gender, height and 
weight was used. 
  Dose was transformed because of skewness on the raw 
scale. For analyses based on small numbers, exact p values and 
CIs were used. 
Figure 1  Subject ﬂ  ow diagram.
09_archdischild189696.indd   543 09_archdischild189696.indd   543 4/25/2011   6:16:53 PM 4/25/2011   6:16:53 PMOriginal article
Arch Dis Child 2011;96:541–547. doi:10.1136/adc.2010.189696 544
  To assess interaction, the Wald test p value associated with 
the product term was taken as an indication of the signiﬁ  -
cance of the difference in effect by sleep position.    25     
  To accommodate the highly skewed distribution of the 
dependent variables, environmental Der p 1 allergen measure-
ments between the two bedding groups where compared using 
the Wilcoxon–Mann–Whitney test. Analyses were conducted 
using Stata 10 (Statacorp 2007: statistical software: Release 10; 
College Station, Texas, USA).     
  R E S U L T S  
  In total, 197 children were randomised with 97 allocated to 
feather bedding and 100 to standard care. No major differ-
ences were observed between the groups (  table 1  ). Overall 
  Table  1      B a s e l i n e   c h a r a c t e r i s t i c s    
 Characteristic 
  Feather bedding (N=97)    Standard care (N=100) 
 %  (n/N)   %  (n/N) 
Female  42.3  (41/97)  32.0  (32/100)
Study site (ACT vs NSW)   34.0 (33/97)   34.0 (34/100)
Age (years)
 7    8.6 (18/97)   12.0 (12/100)
 8    8.2 (8/97)   18.0 (18/100)
 9   19.6 (19/97)   17.0 (17/100)
 10   12.4 (12/97)   18.0 (18/100)
 11   24.7 (24/97)   19.0 (19/100)
 12   13.4 (13/97)   12.0 (12/100)
 13    2.1  (2/97)   4.0  (4/100)
 14    1.0  (1/97)   0.0  (0/100)
Hospital attendance because of asthma   87 (89.7)   88 (88.0)
Problem with sneezing, runny or blocked nose   77 (79.4)   86 (86.0)
Wheezing in past 12 months
 1–3     6  (6.2)   4  (4.0)
 4–12   47 (48.5)   55 (55.0)
  More than 12   44 (45.4)   41 (41.0)
Sleep disturbed by wheezing in past 12 months
 None   15 (15.6)   17 (17.0)
  Less than 1 night per week   54 (56.3)   57 (57.0)
  One or more nights per week   27 (28.1)   26 (26.0)
Speech-limiting wheeze   48 (49.5)   42 (42.0)
Medication
 Preventers   92.8 (90/97)   89.0 (89/100)
 ICS   53.6 (52/97)   54.0 (54/100)
  ICS+  43.3  (42/97)  41.0  (41/100)
  Relievers 100.0 (97/97) 100.0 (100/100)
 Controllers   16.0 (15/97)   11.6 (11/100)
 Controllers  (tablets)   14.0  (13/97)   8.7  (8/100)
 Oral  steroids   67.0 (65/97)   69.0 (69/100)
Skin prick test (number sensitised)
  Standardised cat pelt   24 (24.8)   28 (28.6)
   Dermatophagoides  pteronyssinus    93 (95.9)   96 (98.0)
   Dermatophagoides  farinae    85 (87.6)   85 (86.7)
  Either house dust mite species   97 (100) 100 (100)
 Control     3  (3.1)   2  (2.0)
 Histamine   90 (93.8)   94 (95.9)
 Rye  grass   45 (46.4)   46 (46.9)
 Plantain,  English   27 (27.8)   24 (24.5)
Smoker in household   25 (25.8)   30 (30.0)
Number sleeping in child’s room
 Child  only   66 (68.0)   69 (69.0)
 Two  children   25 (25.8)   28 (28.0)
 Three  children    6  (6.2)   3  (3.0)
   Mean (SD)   Mean (SD) 
Age   10.2 (.79)   10.2 (1.69)
Age of asthma onset    2.4  (1.79)   2.4  (2.04)
Baseline FEV  1 /FVC   (%  predicted)   84 (0.10)  83  (0.09)
      Notes: no differences in signiﬁ  cance for any characteristic between arms at p<0.05. 
  ACT, Australian Capital Territory; FEV  1  , forced expiratory volume in 1 s; FVC, forced volume vital capacity; ICS, inhaled 
  corticosteroids; NSW, New South Wales.     
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the mean age for these children was 10.2 years (SD 1.72) and 
35% (69/197) of the sample were female. The proportion of 
children followed up at 12 months was high, with retention 
rates at 12   months of 98% (95/97) and 94% (94/100) for the 
feather and control groups respectively. No adverse effects 
were reported among the feather group.   
    Table 2   shows that compliance after initial allocation was 
not complete. By trial end, two-thirds of the feather group 
slept with a feather pillow and quilt and a small number of 
children in the standard group were sleeping with a feather 
bedding item (  table 2  ). Both groups had been supplied with an 
occlusive mattress cover, but the use of this cover was slightly 
higher among the standard group at trial end (  table 2  ). 
  The intention-to-treat analysis found no difference in respi-
ratory symptoms (  table 3  ) or quality of life measures (  table 4  ). 
FEV  1  /FVC was 83% for both groups, with a treatment effect 
size of only 0.4% (95% CI −0.29% to 2.5%). There was also 
no signiﬁ  cant change in airway responsiveness measured by 
cold air or methacholine challenge (data not shown). These 
analyses were re-conducted and classiﬁ  ed by full compliance 
rather than intent. The ﬁ  ndings showed that feather pillow 
and quilt use tended to be associated with a decreased risk of 
sleep disturbed because of wheezing, with an OR of 0.34 (95% 
CI 0.09 to 1.27) and, for severe wheeze, of 0.50 (95% CI 0.20 to 
1.24), although the CIs were wide because of small numbers. 
Child respiratory symptoms did not predict non-compliance 
(frequent wheeze, p=0.25; severe wheeze, p=0.13; sleep dis-
turbed because of wheeze, p=0.30). 
    Examination of effect modiﬁ  cation by sleep position 
  Previously the authors reported that the association between 
synthetic quilt use and severe wheeze was more evident in 
children who sleep supine.    13    A similar pattern was observed 
here (  table 5  ). That is, using either the intent-to-treat or the by 
compliance analysis, the feather group was associated with a 
reduced risk of sleep disturbed because of wheezing or severe 
wheeze to a greater extent for children who slept supine com-
pared with those who did not. Feather bedding use was asso-
ciated with a reduced risk of speech-limiting wheeze among 
children who slept on their back (OR 0.00, 95% CI 0.00 to 0.63, 
p=0.02) but not among children who slept non-supine (OR 0.90, 
95% CI 0.32 to 2.51, p=0.7); difference in effect by sleep posi-
tion, p=0.06. The association between feather bedding use and 
lung function did not differ by sleep position (data not shown).   
  Additional  analyses 
  The distribution of asthma medication type and frequency of 
use was similar across the trial arms and further adjustment 
for medication use or occlusive pillow or mattress cover use at 
trial end did not alter the ﬁ  ndings displayed in   tables 3  –  5  .   
    Results for environmental aeroallergen measurement 
  For inhaled exposure using NAS, data were available for 85 of 
102 children, of these, 65 were above the HDM detection cut-
off. Children without feather bedding (n=43) were exposed to 
a median of 15 pg (IQR 1.0–33.7 pg) and those with feather 
bedding (n=42) were exposed to a median of 9.5 pg (IQR 
2.8– 31.3 pg, p value for difference=0.7). For nocturnal aeroal-
lergen collected using air ﬁ  lters, data were available for 100 of 
the 102 children, of whom 69 were above the cut-off. Children 
without feather bedding (n=51) were exposed to a median of 
28.0 pg/ m    3    of Der p 1 (IQR 1.0–66.8 pg/m    3   ) and children with 
feather bedding (n=49) were exposed to a median of 16.0 pg/ m  3   
Der p 1 (IQR 1.0–54.1 pg/m  3  , p value for difference=0.3).     
  Table  3         The effect of feather bedding on respiratory symptoms   
 Outcome 
(in last 12 months) 
  Feather bedding (N=95)    Standard care (N=94) 
  OR* (95% CI)   p  Value   %  (n/N)   n  (%) 
Frequent wheeze (four or more episodes) 63.8 (60/94) 55.3 (52/94) 1.51 (0.83 to 2.76) 0.173
Speech-limiting wheeze 20.2 (19/94) 22.6 (21/93) 0.70 (0.32 to 1.48) 0.350
Sleep disturbed because of wheezing 
(1 or more nights per week)
55.3 (52/94) 50.0 (47/94) 1.17 (0.64 to 2.13) 0.607
      *Adjusted for baseline measure and trial site.     
  Table  2         Bedding characteristics of trial sample at trial end   
 
 Feather  bedding   Standard  care 
 %  (n/N)   %  (n/N) 
Feather pillow any* 71.3 (67/94)   3.2 (3/94)
Feather pillow only* 71.3 (67/94)   3.2 (3/94)
Feather quilt any 71.3 (67/94)   8.5 (8/94)
Feather quilt only 71.3 (67/94)   8.5 (8/94)
Feather pillow and feather quilt both present 66.0 (62/94)   0 (0/94)
Synthetic quilt any   5.3 (5/94) 68.1 (64/94)
Wool quilt any   3.2 (3/94) 16.0 (15/94)
Wool blanket any   6.4 (6/94) 11.7 (11/94)
Cotton blanket any 14.9 (14/94) 20.2 (19/94)
Occlusive cover-pillow   8.5 (8/94) 19.2 (18/94)
Occlusive cover-mattress 70.5 (67/95) 79.8 (75/94)
Innerspring mattress 85.1 (80/94) 84.0 (79/94)
Mattress age >5 years 85.1 (80/94) 78.7 (74/94)
Bunk bed 24.2 (23/95) 20.2 (19/94)
      *All other children used synthetic pillows.     
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  DISCUSSION 
  At trial end, no overall differences in respiratory symptoms, 
l ung  functi on  o r  quali ty  o f  life  w e re  o bse rv ed  1  y ear  afte r  
children with moderate–severe asthma and HDM sensitisa-
tion were all given a mite-occlusive mattress cover and then 
received either feather upper bedding (pillow and quilt) or 
standard bedding care. This null ﬁ  nding could reﬂ  ect a true 
lack of effect or other contributing factors may have produced 
a false negative result. 
  Statistical power was adequate to detect at least a 20% 
reduction in the risk of frequent wheeze and trial participant 
retention was high. Interventions for children with asthma 
that are possibly mediated through allergen reduction will 
appear ineffective if the type of asthma is not carefully char-
acterised and children not sensitised to the putative allergen 
are included. However, here, 100% of trial participants were 
sensitive to one or both of the two HDM species tested at 
baseline and all had troublesome persistent asthma based on 
the level of symptoms required for entry into the study. Other 
components of the bedding environment may also have been 
inﬂ  uential. However, a high proportion of children in both 
groups slept on an occlusive mattress cover (  table 2  ) and fur-
ther adjustment for pillow and mattress cover types did not 
alter the ﬁ  ndings. Asthma medication type and use did not 
differ between groups, and adjustment for this did not alter the 
results; therefore medication is unlikely to have contributed 
to these results. Differences in laundry practices may have 
contributed. Non-compliance with the use of feather bedding 
may have contributed to the null ﬁ  nding. 
  A quarter (27 of 94) of feather group children reported using 
synthetic pillows at trial end and one-third were not sleeping 
with the feather pillow and quilt (  table 2  ). Analysis by compli-
ance rather than intention to treat raised the possibility that 
feather bedding use was associated with reduced respiratory 
symptoms and better lung function, a result in line with the 
observational epidemiological ﬁ  ndings.    1     –      6        15        23         26         27    However, 
this analysis by compliance is not conclusive because it suffers 
from the same potential selection bias problem as the observa-
tional studies in those children with more severe asthma who 
may have been less likely to maintain feather bedding use. 
  This study found that child sleep position inﬂ  uenced bed-
ding–wheeze associations, with a protective effect of feather 
bedding being observed in children who slept in the supine but 
not the prone position. Although based on small numbers, this 
issue was examined a priori and the ﬁ  ndings are consistent 
with previous observations that among children who slept 
supine, feather quilt use was associated with less frequent 
wheeze compared with synthetic quilt use.    14    Thus, it is also 
possible that an interactive effect between sleep position and 
the bedding–wheeze association may have contributed to the 
null result when all sleeping positions are combined together. 
  Environmental Der p 1 aeroallergen levels did not differ sig-
niﬁ  cantly between the groups. However, both groups received 
mattress encasings which constituted at least some interven-
tion and, consistent with the intention of the trial, no other 
measures such as regular laundry were additionally used. 
  In the high mite environment of Sydney, surface allergen 
may have accumulated similarly from non-bedding sources 
onto both types of bedding. In this environment, additional 
interventions such as frequent washing of bedding or the use 
of air ﬁ  lters could be evaluated. 
  Finally it should be noted that the ﬁ  ndings from this study 
pertain to children with asthma and HDM sensitisation, not 
the child population generally. Thus a null result from this 
therapeutic intervention does not rule out a potential protec-
tive effect of feather bedding in relation to the inception of 
asthma. 
  In conclusion, no differences in respiratory symptoms or 
lung function were observed 1 year after children with mod-
erate–severe asthma and HDM sensitisation were all given a 
mite-occlusive mattress cover and then received either feather 
upper bedding (pillow and quilt) or standard bedding care. 
  Table  4         The effect of feather bedding on quality of life   
 Measure 
  Feather bedding (n=91)    Standard care (n=94) 
  Feather vs standard 
difference* effect 
(95% CI)   p  Value 
 Baseline 
 Change 
(12 months)†   Baseline 
 Change 
(12 months)† 
 Mean  (SD)   Mean  (SD)   Mean  (SD)   Mean  (SD) 
Overall 5.13 (1.28) 0.63 (1.13) 5.04 (1.33) 0.64 (1.46)   0.04 (−0.27 to 0.35)‡ 0.80
Activity 4.59 (1.58) 0.51 (1.52) 4.52 (1.66) 0.38 (1.78)   0.17 (−0.23 to 0.57)‡ 0.41
Symptoms 5.18 (1.30) 0.62 (1.18) 5.11 (1.35) 0.63 (1.51)   0.04 (−0.28 to 0.36)‡ 0.82
Emotional function 5.33 (1.35) 0.67 (1.26) 5.22 (1.43) 0.75 (1.59) −0.01 (−0.33 to 0.31)‡ 0.97
      *Feather minus standard: a positive value indicates greater improvement in feather bedding group. 
  †End point minus baseline: a positive change means an improvement. 
  ‡Adjusted for baseline measure and state.     
  Table  5         The association of feather upper bedding (pillow and quilt) and respiratory outcomes by intention-to-treat analysis or by actual bedding 
use, with further consideration of child’s usual sleeping position   
 Outcome 
(in past 12 months) 
  By intention to treat for 
non-supine children 
(n=155) 
  By intention to treat for 
supine children 
(n=53) 
  By actual feather bedding 
use for non-supine children 
(n=103) 
  By actual feather bedding 
use for supine children 
(n=42) 
  OR (95% CI)    OR (95% CI)    OR (95% CI)    OR (95% CI) 
Frequent wheeze 
(four or more episodes)
1.80 (0.79 to 4.11) 1.24 (0.33 to 4.60) 1.88 (0.76 to 4.62) 0.61 (0.11 to 3.51)
Speech-limiting wheeze 1.38 (0.57 to 3.31) 0.35 (0.08 to 1.47) 0.90 (0.32 to 2.51) 0.00 (0.00 to 0.63)
Sleep disturbed because of 
wheezing 
(1 or more nights per week)
1.27 (0.43 to 3.79) 0.00 (0.00 to 0.93) 0.57 (0.13 to 2.36) 0.00 (0.00 to 1.39)
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The ﬁ  ndings have implications for the policy and the design of 
future trials of bedding interventions for child asthma. These 
ﬁ  ndings do not provide support for previous recommenda-
tions that feather bedding should be avoided for children with 
asthma.    15    Chil d  sl e e p  pos i ti o n  sh o ul d  be  co ns i d e r e d  in  th e  
design phase and a pre-RCT washout period, to detect if par-
ents will comply with the bedding intervention, may also be 
required. The potential beneﬁ  t of upper bedding interventions 
in childhood asthma necessitates that further evaluations be 
undertaken with an emphasis on maintaining long-term com-
pliance, additionally considering sleep position and focusing 
on the micro environment immediately adjacent to the airway 
of the sleeping child. 
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